Melissa Epperly
DirectoratRoivant Sciences· In proxies 2022–2024
Melissa Epperly sits on 4 public boards.
Boards1
- Roivant SciencesDirector · 2 yr on the boardIndependentAudit (Chair)—Paid as an executive
%20scale(0.100000,-0.100000)'%20fill='%23000000'%20stroke='none'%3e%3cpath%20d='M3195%205489%20c-380%20-49%20-706%20-317%20-831%20-682%20-56%20-163%20-54%20-112%20-54%20-1773%20l0%20-1534%20590%200%20590%200%200%201465%200%201465%20600%200%20600%200%200%20535%200%20535%20-712%20-1%20c-392%20-1%20-744%20-6%20-783%20-10z'/%3e%3c/g%3e%3c/svg%3e)
Board seats come from each company's latest proxy statement.
Experience
- Roivant SciencesPublic company · 4 yr
- Director2022 – Present · 4 yrStock in role +356%
- Kinnate Biopharma Inc.Public company
- Director? – PresentNo stock prices for these years
- Nautilus BiotechnologyPublic company
- Director? – PresentNo stock prices for these years
- Anchorage Capital GroupPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?